Surveillance of AMR in DRC

Launched by UNIVERSITY OF OXFORD · Feb 6, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a serious condition called bacteremia, which is an infection in the bloodstream. The research aims to understand how common antibiotic resistance is in the Democratic Republic of Congo (DRC). This is important because antibiotic resistance makes it harder to treat infections. The study will take place at a hospital in Kinshasa, where researchers will look at different bacterial infections, how they resist treatment, and other factors that might affect patients' health, including other infections like malaria.

To participate in this trial, patients must be at least six months old and show signs of a bloodstream infection when they arrive at the hospital. They need to give their consent or have a parent or guardian give consent for them. However, patients who have had significant medical treatment recently or who cannot have their blood drawn will not be eligible. If you join the study, you will help improve our understanding of infections in the region, which could lead to better treatment options in the future.

Gender

ALL

Eligibility criteria

• • Patients older than six months who present with a clinically suspected bloodstream infection upon admission to the hospital, or who have been hospitalized for less than 48 hours, and provide written consent (or consent from their caregiver/legal guardian) to participate will be included. Patients with a significant history of healthcare exposure and those with any contraindications for phlebotomy as determined by the clinician's judgment, will be excluded.